Drug Type Monoclonal antibody |
Synonyms APG 333, APG-333 |
Target |
Mechanism TSLP inhibitors(Thymic stromal lymphopoietin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Preclinical | US | 12 Aug 2024 | |
Pulmonary Disease, Chronic Obstructive | Preclinical | US | 12 Aug 2024 |